IL13 and neoplasm: Our study was then further designed to target MPNST cancer cells using IL13 conjugated liposomes to selectively target and deliver the encapsulated chemotherapeutic agent to improve its therapeutic index and decrease tumor progression in mice bearing MPNSTs.